Across TCGA pan-cancer cohorts, NHLRC3 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated NHLRC3 data layer compared with 26 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher NHLRC3 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated NHLRC3 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

HNSC, LUAD, and UCEC are the cancer types where NHLRC3 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	II,III,IV	0.002	0.757	<.001	48	view →
LUAD	OS	Median	All	0.057	0.812	<.001	36	view →
UCEC	DFS	Median	All	0.947	0.628	.040	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: NHLRC3 tumor-vs-normal RNA expression · all NHLRC3 data types